RICHMOND SURGERY — All Prescriptions & Medications — Page 8
Practice Code: J82099 | FLEET, GU52 7US
Showing results 351-400 of 635
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diclofenac sodium | 57 | 3,150 | £2.3K | +137.8% ▲ |
| Bezafibrate | 56 | 996 | £150 | +4.0% ▲ |
| Guanfacine | 56 | 1,736 | £3.7K | +117.9% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 56 | 57.9K | £898 | +144.4% ▲ |
| Urea | 56 | 22.0K | £834 | -16.2% ▼ |
| Prucalopride | 55 | 2,828 | £2.1K | +41.3% ▲ |
| Formoterol/glycopyrronium/budesonide | 55 | 55 | £2.3K | -8.7% ▼ |
| Ciprofloxacin | 54 | 675 | £59 | +35.4% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 54 | 2,549 | £1.3K | +110.2% ▲ |
| 54 | 191 | £78 | -47.1% ▼ | |
| 54 | 3,630 | £916 | +97.8% ▲ | |
| Alverine citrate | 53 | 5,522 | £240 | +28.1% ▲ |
| Phenobarbital | 53 | 3,407 | £364 | +72.4% ▲ |
| Glucose | 53 | 7,895 | £691 | +1.9% vs avg |
| Clotrimazole | 53 | 632 | £478 | -52.0% ▼ |
| Travoprost | 53 | 303 | £544 | +12.5% ▲ |
| Nebivolol | 52 | 1,939 | £262 | -50.9% ▼ |
| Erythromycin | 52 | 4,088 | £1.7K | +50.1% ▲ |
| Ketone blood testing reagents | 52 | 1,060 | £1.0K | -23.2% ▼ |
| Piroxicam | 52 | 4,804 | £125 | -9.5% ▼ |
| 52 | 56 | £85 | -76.4% ▼ | |
| Diclofenac sodium | 51 | 3,814 | £104 | +0.5% vs avg |
| Salmeterol | 50 | 71 | £2.0K | +107.9% ▲ |
| Metformin hydrochloride/sitagliptin | 50 | 4,032 | £2.3K | +33.6% ▲ |
| Tacrolimus | 50 | 1,920 | £1.5K | -7.3% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 50 | 2,220 | £962 | -25.4% ▼ |
| Other individually formulated bought in preparations | 50 | 2,326 | £2.6K | +53.0% ▲ |
| 50 | 139 | £527 | +61.2% ▲ | |
| Sodium citrate (Rectal) | 49 | 1,302 | £847 | +255.1% ▲ |
| Sodium chloride | 49 | 3,490 | £2.0K | +64.7% ▲ |
| Alogliptin | 48 | 1,358 | £1.2K | -81.1% ▼ |
| 48 | 3,540 | £2.5K | +45.1% ▲ | |
| Ins degludec/liraglutide | 47 | 251 | £8.0K | +192.4% ▲ |
| Denosumab | 47 | 47 | £8.6K | +72.7% ▲ |
| Ergocalciferol | 47 | 488 | £239 | +180.8% ▲ |
| Amisulpride | 46 | 1,246 | £592 | -34.6% ▼ |
| Duloxetine hydrochloride | 46 | 1,680 | £424 | -10.2% ▼ |
| Budesonide | 45 | 1,984 | £1.6K | +187.2% ▲ |
| Ticagrelor | 45 | 3,476 | £3.4K | -47.1% ▼ |
| Cyproterone acetate | 45 | 1,260 | £1.5K | +309.9% ▲ |
| Brinzolamide/brimonidine | 45 | 295 | £518 | +31.2% ▲ |
| 45 | 160 | £10.1K | +26.0% ▲ | |
| Tiotropium bromide/olodaterol | 44 | 54 | £1.7K | -28.3% ▼ |
| Dosulepin hydrochloride | 44 | 2,408 | £515 | -22.3% ▼ |
| Tibolone | 44 | 2,765 | £252 | +43.8% ▲ |
| Medroxyprogesterone acetate | 44 | 3,421 | £651 | +15.0% ▲ |
| Mycophenolate mofetil | 44 | 6,788 | £2.5K | +8.7% ▲ |
| Erythromycin | 44 | 2,310 | £1.1K | +224.0% ▲ |
| 44 | 3,650 | £272 | -36.9% ▼ | |
| Naratriptan hydrochloride | 43 | 330 | £108 | +64.5% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.